Find Elesclomol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 488832-69-5, Sta-4783, Elesclomol (sta-4783), N'1,n'3-dimethyl-n'1,n'3-di(phenylcarbonothioyl)malonohydrazide, Elesclomol [usan], Chebi:79369
Molecular Formula
C19H20N4O2S2
Molecular Weight
400.5  g/mol
InChI Key
BKJIXTWSNXCKJH-UHFFFAOYSA-N
FDA UNII
6UK191M53P

Elesclomol
Elesclomol is a small-molecule bis(thio-hydrazide amide) with oxidative stress induction, pro-apoptotic, and potential antineoplastic activities. Elesclomol induces oxidative stress, creating high levels of reactive oxygen species (ROS), such as hydrogen peroxide, in both cancer cells and normal cells. Because tumor cells have elevated levels of ROS compared to normal cells, the increase in oxidative stress beyond baseline levels elevates ROS beyond sustainable levels, exhausting tumor cell antioxidant capacity, which may result in the induction of the mitochondrial apoptosis pathway. Normal cells are spared because the increase in the level of oxidative stress induced by this agent is below the threshold at which apoptosis is induced.
1 2D Structure

Elesclomol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-N',3-N'-bis(benzenecarbonothioyl)-1-N',3-N'-dimethylpropanedihydrazide
2.1.2 InChI
InChI=1S/C19H20N4O2S2/c1-22(18(26)14-9-5-3-6-10-14)20-16(24)13-17(25)21-23(2)19(27)15-11-7-4-8-12-15/h3-12H,13H2,1-2H3,(H,20,24)(H,21,25)
2.1.3 InChI Key
BKJIXTWSNXCKJH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2
2.2 Other Identifiers
2.2.1 UNII
6UK191M53P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Sta 4783

2. Sta-4783

3. Sta4783

2.3.2 Depositor-Supplied Synonyms

1. 488832-69-5

2. Sta-4783

3. Elesclomol (sta-4783)

4. N'1,n'3-dimethyl-n'1,n'3-di(phenylcarbonothioyl)malonohydrazide

5. Elesclomol [usan]

6. Chebi:79369

7. Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]

8. 6uk191m53p

9. Gsk-842879a

10. Elesclomol (usan)

11. Gsk-842879

12. 1,3-bis[2-methyl-2-(phenylthioxomethyl)hydrazide]propanedioic Acid

13. 1-n',3-n'-bis(benzenecarbonothioyl)-1-n',3-n'-dimethylpropanedihydrazide

14. 1-n'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-n'-methyl-oxopropanehydrazidide

15. Elesclomol [usan:inn]

16. Elesclomolum

17. Unii-6uk191m53p

18. N'1,n'3-dimethyl-n'1,n'3-bis(phenylcarbonothioyl)propanedihydrazide

19. Propanedioic Acid, Bis(2-methyl-2-(phenylthioxomethyl)hydrazide)

20. Sta4783

21. Sta 4783

22. Nsc174939

23. Elesclomol [mi]

24. Elesclomol [inn]

25. Elesclomol [mart.]

26. Elesclomol [who-dd]

27. Mls006011164

28. Schembl313745

29. Chembl1972860

30. Dtxsid2042642

31. Schembl10131773

32. Ex-a602

33. Hms3654m11

34. Hms3868i03

35. Bcp00247

36. Zinc1716098

37. Mfcd12911784

38. S1052

39. Akos005145783

40. Bcp9000639

41. Ccg-264795

42. Cs-0192

43. Db05719

44. Nsc-174939

45. Sb17208

46. Ncgc00183656-01

47. Ncgc00183656-02

48. Ncgc00183656-09

49. Ncgc00183656-11

50. Ac-35840

51. As-56232

52. Hy-12040

53. Nci60_001429

54. Smr004702933

55. Ft-0700480

56. Sw219775-1

57. Ec-000.2312

58. A23836

59. D08909

60. H11160

61. 832e695

62. J-503879

63. N-malonyl-bis (n'-methyl-n'-thiobenzoyl Hydrazide)

64. Q5359460

65. Brd-k82135108-001-01-9

66. N,n'-bis[methyl[phenyl(thiocarbonyl)]amino]malonamide

67. N'(1),n'(3)-dimethyl-n'(1),n'(3)-bis(phenylcarbonothioyl)malonohydrazide

68. 1-n'-benzenecarbothioyl-3-(2-benzene Carbothioyl-2-methylhydrazinyl)-n'-methyloxopropanehydrazidide

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 400.5 g/mol
Molecular Formula C19H20N4O2S2
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass400.10276824 g/mol
Monoisotopic Mass400.10276824 g/mol
Topological Polar Surface Area129 Ų
Heavy Atom Count27
Formal Charge0
Complexity510
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in melanoma.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Elesclomol is a first-in-class heat shock protein 70 (Hsp70) inducer that activates natural killer (NK) cell-mediated tumor killing.


5.2 Mechanism of Action

Elesclomol acts through a novel mechanism of action. Elesclomol has been shown to rapidly cause a dramatic increase in oxidative stress (ROS) inside cancer cells. The prolonged elevation of ROS inside cancer cells induced by elesclomol causes the cell to exceed a critical breaking point and undergo apoptosis. The triggering of the mitochondrial apoptosis pathway is observed within the first six hours of applying elesclomol. Cancer cells operate at a much higher intrinsic level of ROS than normal cells, and have a greatly reduced anti-oxidant capacity compared to normal cells. This leaves them more vulnerable to an agent such as elesclomol that elevates oxidative stress. In similar experiments at similar doses, elesclomol has been found to have little to no impact on normal cells.


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty